Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome

References

• Morrell DS, Pepping MA, Scott JP, et al. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch dermatol. 2002;138(9):1208–1212. doi: 10.1001/archderm.138.9.1208
   PubMedGoogle Scholar
• Gadoury-Levesque V, Dong L, Su R, et al. Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders. Blood Adv. 2020 23;4(12):2578–2594. doi: 10.1182/bloodadvances.2020001605
   PubMed Web of Science ®Google Scholar
• Koh KN, Im HJ, Chung NG, et al. Korea histiocytosis working party. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol. 2015;94(1):51–59. doi: 10.1111/ejh.12399
   PubMed Web of Science ®Google Scholar
• Madkaikar M, Shabrish S, Desai M. Current updates on classification, diagnosis and treatment of hemophagocytic lymphohistiocytosis (HLH). Indian J Pediatr. 2016;83(5):434–443. doi: 10.1007/s12098-016-2037-y
   PubMed Web of Science ®Google Scholar
• George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69–86. doi: 10.2147/JBM.S46255
   PubMedGoogle Scholar
• Picard C, Al-Herz W, Bousfiha A, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726. doi: 10.1007/s10875-015-0201-1
   PubMed Web of Science ®Google Scholar
• Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006;38(1):20–31. doi: 10.1080/07853890500465189
   PubMed Web of Science ®Google Scholar
• Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis. Blood. 2019 Nov 21;134(21):1783–1786.
   PubMed Web of Science ®Google Scholar
• Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL study group of the histiocyte society. Semin Oncol. 1991;18(1):29–33.
   PubMed Web of Science ®Google Scholar
• Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131. doi: 10.1002/pbc.21039
   PubMed Web of Science ®Google Scholar
• Malloy CA, Polinski C, Alkan S, et al. Hemophagocytic lymphohistiocytosis presenting with nonimmune hydrops fetalis. J Perinatol. 2004;24(7):458–460. doi: 10.1038/sj.jp.7211121
   PubMedGoogle Scholar
• Ramachandran B, Balasubramanian S, Abhishek N, et al. Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr. 2011;48(1):31–35. doi: 10.1007/s13312-011-0020-2
   PubMed Web of Science ®Google Scholar
• Crossley BM, Bai J, Glaser A, et al. Guidelines for Sanger sequencing and molecular assay monitoring. J Vet Diagn Invest. 2020 Nov;32(6):767–775.
   PubMed Web of Science ®Google Scholar
• Nagai K, Yamamoto K, Fujiwara H, et al. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PLOS ONE. 2010;5(11):e14173. doi: 10.1371/journal.pone.0014173
   PubMed Web of Science ®Google Scholar
• Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041–4052. doi: 10.1182/blood-2011-03-278127
   PubMed Web of Science ®Google Scholar
• Elyamany G, Alzahrani A, Elfaraidi H, et al. Hemophagocytic lymphohistiocytosis: single-center series of 12 cases from Saudi Arabia. Clin Med Insights Pediatr. 2016 Apr 5;10:21–26.
   PubMedGoogle Scholar
• Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6(6):601–608. doi: 10.3201/eid0606.000608
   PubMed Web of Science ®Google Scholar
• Toga A, Wada T, Sakakibara Y, et al. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J Infect Dis. 2010;201(12):1923–1932. doi: 10.1086/652752
   PubMed Web of Science ®Google Scholar
• Tsuda H, Fujisao S. Th1/Th2 milieu in adult hemophagocytic syndrome. Acta Haematol. 1999;101(3):157–160. doi: 10.1159/000040944
   PubMed Web of Science ®Google Scholar
• Imashuku S, Hyakuna N, Funabiki T, et al. Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis. Cancer. 2002;94(11):3023–3031. doi: 10.1002/cncr.10515
   PubMed Web of Science ®Google Scholar
• Sung L, King SM, Carcao M, et al. Adverse outcomes in primary hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2002;24(7):550–554. doi: 10.1097/00043426-200210000-00011
   PubMed Web of Science ®Google Scholar
• Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58–65. doi: 10.1532/IJH97.07012
   PubMed Web of Science ®Google Scholar
• Bergsten E, Horne A, Arico M, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728–2738. doi: 10.1182/blood-2017-06-788349
   PubMed Web of Science ®Google Scholar
• Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the histiocyte society. Med Pediatr Oncol. 1997;28(5):342–347. doi: 10.1002/(SICI)1096-911X(199705)28:5<342:AID-MPO3>3.0.CO;2-H
   PubMedGoogle Scholar
• Shawky RM, El-Awady MY, Elsayed SM, et al. Consanguineous matings among Egyptian population. Egyptian J Med Hum Genet. 2011;12(2):157–163. doi: 10.1016/j.ejmhg.2011.07.001
   Google Scholar
• Bhattacharyya M, Ghosh MK. Hemophagoctic lymphohistiocytosis--recent concept. J Assoc Physicians India. 2008;56:453–457.
   PubMedGoogle Scholar
• Kleynberg RL, Schiller GJ. Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy. Clin Adv Hematol Oncol. 2012;10(11):726–732.
   PubMedGoogle Scholar
• Elalfy MS, Ragab IA, AbdelAal NM, et al. Study of the diagnostic criteria for hemophagocytic lymphohistiocytosis in neonatal and pediatric patients with severe sepsis or septic shock. Pediatr Hematol Oncol. 2021 Aug;38(5):486–496. doi: 10.1080/08880018.2021.1887983
   PubMed Web of Science ®Google Scholar
• Elsayed S, Elsobky E, Tantawy A, et al. Wolman disease in patients with familial hemophagocytic lymphohistiocytosis (FHL) negative mutations. Egyptian J Med Hum Genet. 2016;17(3):277–280. doi: 10.1016/j.ejmhg.2015.08.005
   Google Scholar
• Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol. 2002;5(2):130–140. doi: 10.1007/s10024001-0159-2
   PubMed Web of Science ®Google Scholar
• Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis. 2003;36(3):306–312. doi: 10.1086/345903
   PubMed Web of Science ®Google Scholar
• Sailler L, Duchayne E, Marchou B, et al. Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients. Rev Med Interne. 1997;18(11):855–864. doi: 10.1016/S0248-8663(97)81959-5
   PubMed Web of Science ®Google Scholar
• Horne A, Trottestam H, Arico M, et al. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2008;140(3):327–335. doi: 10.1111/j.1365-2141.2007.06922.x
   PubMed Web of Science ®Google Scholar
• Pagel J, Beutel K, Lehmberg K, et al. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119(25):6016–6024. doi: 10.1182/blood-2011-12-398958
   PubMed Web of Science ®Google Scholar
• Kim MM, Yum MS, Choi HW, et al. Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis. Korean J Hematol. 2012;47(4):273–280. doi: 10.5045/kjh.2012.47.4.273
   PubMedGoogle Scholar
• Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27(136):519–525. doi: 10.1136/adc.27.136.519
   PubMed Web of Science ®Google Scholar
• Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the international registry. FHL study group of the histiocyte society. Leukemia. 1996;10(2):197–203.
   PubMed Web of Science ®Google Scholar
• Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140(3):221–230. doi: 10.1007/BF00443367
   PubMed Web of Science ®Google Scholar
• Ishii E, Ohga S, Imashuku S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol. 2005;53(3):209–223. doi: 10.1016/j.critrevonc.2004.11.002
   PubMed Web of Science ®Google Scholar
• Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6(1):137–154. doi: 10.1586/eci.09.58
   PubMed Web of Science ®Google Scholar
• Behrens EM, Beukelman T, Paessler M, et al. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34(5):1133–1138.
   PubMed Web of Science ®Google Scholar
• Filipovich AH. Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. Pediatr Transplant. 2005;9(Suppl 7):87–91. doi: 10.1111/j.1399-3046.2005.00449.x
   PubMedGoogle Scholar
• Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics. 2006;117(4):e743–750. doi: 10.1542/peds.2005-1789
   PubMed Web of Science ®Google Scholar
• Henter JI, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367–2373. doi: 10.1182/blood-2002-01-0172
   PubMed Web of Science ®Google Scholar
• Wegehaupt O, Wustrau K, Lehmberg K, et al. Cell versus cytokine - directed therapies for hemophagocytic lymphohistiocytosis (hlh) in inborn errors of immunity. Front Immunol. 2020 May 8;11:808. doi: 10.3389/fimmu.2020.00808
   PubMed Web of Science ®Google Scholar
• Elsharkawy A, Assem H, Salama M, et al. Clinical characteristics and outcomes of 101 children with hemophagocytic lymphohistiocytosis: a four-year single-center experience from Egypt. Pediatr Hematol Oncol. 2021 Apr;38(3):194–207.
   PubMed Web of Science ®Google Scholar
• Trottestam H, Berglof E, Horne A, et al. Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta Paediatr. 2012;101(3):313–318. doi: 10.1111/j.1651-2227.2011.02501.x
   PubMed Web of Science ®Google Scholar
• Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484–492. doi: 10.1016/j.mayocp.2013.12.012
   PubMed Web of Science ®Google Scholar
• Kogawa K, Sato H, Asano T, et al. Prognostic factors of epstein-barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014;61(7):1257–1262. doi: 10.1002/pbc.24980
   PubMed Web of Science ®Google Scholar
• Sparber-Sauer M, Honig M, Schulz AS, et al. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation. Bone Marrow Transplant. 2009;44(6):333–338. doi: 10.1038/bmt.2009.34
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. [cited 2024 Jan 12]. Available from: https://www.fda.gov/drugs/fda-approves-emapalumab-hemophagocytic-lymphohistiocytosis
   Google Scholar